Evaluate the Safety and Potential Efficacy of Human Wharton's Jelly-derived Mesenchymal Stem Cells With Charcot-Marie-Tooth Disease Type 1E
Clinical trial NCT06218134 · COMPLETED
Trial details
- NCT number
- NCT06218134
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-23
- Primary completion
- 2024-10-28
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.